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Purpose
Intra-articular corticosteroid injection (IACI) with
triamcinolone hexacetonide (TH) is a mainstay of ther-
apy for patients with juvenile idiopathic arthritis (JIA).
Our aim was to determine factors that affected the dur-
ability of response to IACI with TH in patients with
JIA.
Methods
A retrospective chart review was conducted of all JIA
patients who received IACI from 6/05 to 3/10, and had
at least six months of follow-up. Data collected included
demographic information, JIA subtype, date of injection
and arthritis flare, type of joint injected and concomitant
medications. Any joint that did not flare by the study
end date in 9/10 was censored. Time to flare of arthritis
was calculated based on the Kaplan-Meier product limit
estimator. Two-sided log-rank test was conducted to
compare the time to flare within each characteristic
group: joints, diagnosis, medications. All analysis in this
study was performed using SAS 9.2 (SAS Institute Inc,
Cary, NC).
Results
There were 112 patients (83 females) and 198 separate
joints included in the study. Fourteen (7.1%) joints did
not respond to their first IACI. Of the 184 joints that
did respond to the initial IACI, 99 (53.8%) fully
improved and did not relapse during the study period
(duration of follow-up: mean 723.7 ±421 days; median
553 days, IQR 385-994). There was a significant differ-
ence in time to flare between elbow and wrist joints.
Although hip joints showed the shortest time to flare,
the sample size was too small to tell if the difference
was significant.
Twenty to 36% of each joint type received a second
IACI. About a third of the re-injected knee joints
required a third IACI, and all four of the re-injected hip
joints received a third IACI.
Conclusion
IACI is an effective therapy for patients with JIA with
the majority of patients having complete and long-last-
ing response to IACI. Over half of the injected joints
did not relapse after a mean and median follow up of
23.7 months and 18.2 months, respectively. There was a
significant difference in median time to flare between
the elbow and wrist joints. Knees had the longest med-
ian time to relapse and hips the shortest; however, a lar-
ger sample is needed to determine if these represent
significant differences. Systemic arthritis showed the
shortest time to relapse, and was statistically different
from oligoarthritis and polyarthritis. Concomitant medi-
cations did not have a significant effect on flare times. A
larger study population is needed to better evaluate the
effect of joint type and other factors on risk of recurrent
flares.
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Table 1 Factors affecting flare in JIA patients post-ICAI (n=184)
Characteristic Flared (5) Time to flare median (days) p-value**
Joint
Knee (n=112 55 (49.1) 972.0
Ankle (n=30) 12 (39.9) 903 0.0297†
Wrist (n=17) 11 (64.7) 569.0
Elbow (m=14) 2 (14.3) 243
Diagnosis
Oligoarthritis (n=97) 39 (40.2) 1042.0
Polyarthritis (n=40) 15 (37.5) 903.0
Extended oligoarthritis (n=23) 14 (60.9) 569.0 0.0003††
Systemic arthritis (n=14) 11 (78.6) 276.0
Enthesits-related arthritis (n=6) 3 (50.0) 629.0
Psoriatic arthritis (n=2) 1 (50.0) 797.0*
Medications
DMARD
No (n=116) 53 (45.7) 846.0 0.8660
Yes (n=68) 32 (47.1) 903.0
Biologics
No (n=141) 64 (44.4) 972.0 0.0729
Yes (n=43) 21 (48.8) 615.0
NSAID
No (n=84) 42 (50.0) 797.0 0.1353
Yes (n=100) 43 (43.0) 972.0
*Median not estimated by SAS; the reported value is the 25th percentile.
**p-value<0.05 was considered statistically significant.
†A significant difference between joint types was found for elbow vs. wriset joint (p=0.0180) after adjusting for multiple testing using a Hochberg procedure.
††A significant difference between JIA subtypes was found for oligoarthritis vs. systemic arthritis (p=0.0015) and between polyarthritis vs. systemic arthritis
(p=0.0084) after adjusting for multiple testing using Hochberg procedure.
Table 2 Repeat IACI in JIA patients with arthritis flare
Joint Flare afer second IACI n(%) Flare after third IACI n(%)
Total injected Joints flared Total injected Joints flared
Knee 37 15 (40.54) 13 6 (46.15)
Ankle 6 6 (100.00) 0 0 (0.00)
Wrist 5 1 (20.00) 0 0 (0.00)
Elbow 3 1 (33.33) 1 1 (100.00)
Hip 4 4 (100.00) 4 4 (100.00)
Total 55 27 18 11
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